{"meta":{"query_hash":"ae66f543bf4a","filters":{"venue":"Clinical and Translational Discovery"},"cohort_total":9,"direct_labels_cover":0,"predictions_cover":9,"exported":9,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ae66f543bf4a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+and+Translational+Discovery"},"results":[{"id":"W4281691501","doi":"10.1002/ctd2.40","title":"Overview of recent advances in Vero cells genomic characterization and engineering for high‐throughput vaccine manufacturing","year":2022,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Vero cell; Virology; Bioprocess; Biology; Cell culture; Virus; Genetics","score_opus":0.0235398614249051,"score_gpt":0.30479973201728777,"score_spread":0.28125987059238267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281691501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990649,0.005543356,0.0030846847,0.000104907325,0.00021646786,0.00015190414,0.00023979203,0.000002441601,0.00000748454],"genre_scores_gemma":[0.98417443,0.015110102,0.00013212251,0.00010581742,0.00009314245,0.000032463355,0.00032121345,0.0000074431096,0.000023245148],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994182,0.000026009197,0.00024674216,0.000188826,0.000050244358,0.000069961854],"domain_scores_gemma":[0.9998103,0.000040252293,0.000056623125,0.000056369772,0.000010309678,0.00002613949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009991168,0.00006598117,0.000117289754,0.000020511032,0.000046981902,0.000008285444,0.000032959022,0.00003316618,0.000021241456],"category_scores_gemma":[0.000010066214,0.000063831474,0.000045224824,0.000023983175,0.000016643431,0.000016813226,0.000039246614,0.000047856094,7.429517e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019705545,0.0006128064,0.0996737,0.00071603956,0.00012743274,0.0000024030371,0.00007070835,0.015298805,0.7896086,0.0026330634,0.000102779835,0.0891831],"study_design_scores_gemma":[0.0028720591,0.0005836326,0.8758719,0.00004240772,0.000035070523,0.0000033680994,0.000014339903,0.0005916281,0.042837333,0.0017847487,0.07511324,0.00025030927],"about_ca_topic_score_codex":0.000002086003,"about_ca_topic_score_gemma":0.000003635547,"teacher_disagreement_score":0.77619815,"about_ca_system_score_codex":0.0000022360077,"about_ca_system_score_gemma":0.000018630682,"threshold_uncertainty_score":0.2602972},"labels":[],"label_agreement":null},{"id":"W4281761878","doi":"10.1002/ctd2.90","title":"MicroRNA‐200c overexpression in cancer‐associated fibroblasts decreases interleukin‐2 secretion","year":2022,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Isfahan University of Medical Sciences","keywords":"Lipofectamine; Transfection; Secretion; Fibroblast; Chemistry; Molecular biology; Interleukin; Cancer-Associated Fibroblasts; Biology; Cancer; Cancer cell; Cytokine; Internal medicine; Endocrinology; Immunology; Medicine; Biochemistry; In vitro; Gene","score_opus":0.02173926196895268,"score_gpt":0.313464854498288,"score_spread":0.2917255925293353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281761878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748796,0.001305356,0.00026839532,0.00025903463,0.0001015904,0.00015963666,0.00031046447,0.000007728897,0.00009980155],"genre_scores_gemma":[0.9979642,0.00017168932,0.000056842437,0.0001995152,0.000118742064,0.000045965477,0.0012270033,0.000013198421,0.00020286991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882436,0.00019111321,0.0003555965,0.0003395188,0.00015282717,0.00013657636],"domain_scores_gemma":[0.99964064,0.00006459008,0.00009643528,0.00010751808,0.00002511965,0.000065705506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002105793,0.00011013064,0.00013382819,0.000041378098,0.00010098583,0.000021650885,0.00008398813,0.00008951359,0.000107971784],"category_scores_gemma":[0.000065526314,0.00011195847,0.000112707414,0.00008762849,0.00009228636,0.000018630928,0.00008087303,0.00013580674,8.6547635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016362362,0.00086306984,0.50070846,0.00005361105,0.00011542339,0.0000074297704,0.00006776426,0.0038022276,0.4862717,0.0005048036,0.0018335928,0.0041356403],"study_design_scores_gemma":[0.0023106711,0.0002289378,0.9807957,0.0001569056,0.000025752193,0.000006834701,0.000035420664,0.0011090297,0.007903931,0.0020952662,0.005067008,0.00026455737],"about_ca_topic_score_codex":0.000048805166,"about_ca_topic_score_gemma":0.000107391505,"teacher_disagreement_score":0.4800872,"about_ca_system_score_codex":0.000016580665,"about_ca_system_score_gemma":0.00012697306,"threshold_uncertainty_score":0.45655337},"labels":[],"label_agreement":null},{"id":"W4384407311","doi":"10.1002/ctd2.205","title":"Profiling of circulating serum exosomal microRNAs in elderly patients with infectious stress hyperglycaemia","year":2023,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto","funders":"Banting and Best Diabetes Centre, University of Toronto; Basic and Applied Basic Research Foundation of Guangdong Province; University of Toronto; National Natural Science Foundation of China; Natural Science Foundation of Shenzhen City","keywords":"Cohort; Medicine; microRNA; Internal medicine; Disease; Exosome; Cohort study; Coronavirus disease 2019 (COVID-19); Logistic regression; Oncology; Bioinformatics; Microvesicles; Infectious disease (medical specialty); Biology; Gene","score_opus":0.01260874511101238,"score_gpt":0.2734294441525424,"score_spread":0.26082069904153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384407311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892336,0.00020607299,0.0003187829,0.000036784735,0.000058900976,0.0001600212,0.00014749049,0.000008931109,0.00013965604],"genre_scores_gemma":[0.99915916,0.000035152825,0.00026172897,0.000024483132,0.00006895245,0.000007413605,0.00039522897,0.000014136359,0.0000337452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990637,0.000054969874,0.00034645814,0.00027145765,0.0001255155,0.00013792986],"domain_scores_gemma":[0.99964553,0.00007041432,0.00007262605,0.000117609656,0.00004258261,0.000051239793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013871539,0.00009734257,0.0001377383,0.000038871574,0.000034095436,0.000014280817,0.00006176158,0.0001016452,0.0000027898218],"category_scores_gemma":[0.000063500425,0.00008582215,0.0000707413,0.0001205317,0.00014588746,0.000016602757,0.000029610486,0.00009833729,0.0000014450978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015629569,0.00016738643,0.9869762,0.000058392998,0.000034934652,0.000005855437,0.000014487852,0.00070109236,0.008743424,0.00016283563,0.0000036009137,0.0029754948],"study_design_scores_gemma":[0.0016609784,0.00017512662,0.9932078,0.00005371288,0.000016907066,0.0000011698049,0.000019655534,0.00018622431,0.004102593,0.00043379897,0.000023895967,0.00011811531],"about_ca_topic_score_codex":0.000003728013,"about_ca_topic_score_gemma":0.000032608154,"teacher_disagreement_score":0.0062316232,"about_ca_system_score_codex":0.0000016588402,"about_ca_system_score_gemma":0.000066862136,"threshold_uncertainty_score":0.34997255},"labels":[],"label_agreement":null},{"id":"W4385794587","doi":"10.1002/ctd2.227","title":"Lymph node metastasis in oral squamous cell carcinoma: Where we are and where we are going","year":2023,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Medicine; Immunotherapy; Neck dissection; Lymph node; Metastasis; Oncology; Cancer; Dissection (medical); Clinical trial; Radiology; Internal medicine","score_opus":0.0705476701719316,"score_gpt":0.34323206320238137,"score_spread":0.2726843930304498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385794587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93051505,0.044482745,0.000036980106,0.023485769,0.0001782975,0.00018727721,0.00022268326,0.0000390976,0.0008520923],"genre_scores_gemma":[0.98488545,0.013334512,0.00013172031,0.00031746528,0.00018550515,0.000018826915,0.000032534812,0.00002052154,0.0010734552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850225,0.00007764673,0.0004993301,0.00042404621,0.0002347839,0.00026195004],"domain_scores_gemma":[0.998993,0.0006259176,0.00007501429,0.00012265937,0.00003646372,0.00014695206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027377481,0.00018762046,0.000598714,0.000085168154,0.00010787135,0.000034264423,0.00004471168,0.00012540359,0.00003789769],"category_scores_gemma":[0.000056732784,0.00014847898,0.00014973975,0.00024001148,0.00019588816,0.00019797147,0.000039350045,0.000237695,0.00002315436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003249981,0.00017732893,0.98948103,0.0010049837,0.000039598413,0.00014378178,0.00029800262,0.000022846,0.000022112441,0.000107650645,0.0018504688,0.0065271766],"study_design_scores_gemma":[0.0044560633,0.00010073576,0.9870778,0.00055466907,0.00013088094,0.0000090021085,0.000711149,0.0004592201,0.0000145225695,0.0006467899,0.005662023,0.00017717929],"about_ca_topic_score_codex":0.000048766633,"about_ca_topic_score_gemma":0.0008299474,"teacher_disagreement_score":0.054370403,"about_ca_system_score_codex":0.000011623609,"about_ca_system_score_gemma":0.00010546721,"threshold_uncertainty_score":0.6054797},"labels":[],"label_agreement":null},{"id":"W4403174248","doi":"10.1002/ctd2.70009","title":"Developing messenger RNA biomarkers: A workflow to characterise and identify transcript target sequences unaffected by alternative splicing for reproducible gene transcript quantification by reverse transcriptase quantitative polymerase chain reaction","year":2024,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Reverse transcriptase; RNA splicing; Biology; Messenger RNA; Gene; Alternative splicing; Mature messenger RNA; Computational biology; RNA; Post-transcriptional modification; Genetics","score_opus":0.05534122912123656,"score_gpt":0.375574750912204,"score_spread":0.3202335217909674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403174248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80829614,0.009215541,0.17494255,0.0051358743,0.0002968296,0.000754393,0.0013189053,0.000022190223,0.000017553013],"genre_scores_gemma":[0.98842305,0.002424674,0.0052526114,0.0004170308,0.00018690687,0.00013476622,0.0022098632,0.00004102349,0.0009100486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976061,0.00020369439,0.0005927111,0.0010644937,0.00021775236,0.00031523936],"domain_scores_gemma":[0.99925137,0.00020155834,0.00007005822,0.00018866234,0.000092561415,0.00019581296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009815483,0.00025570637,0.00030199334,0.00011198796,0.00018829727,0.00021038912,0.000111319496,0.00016838642,0.0000061918745],"category_scores_gemma":[0.00014627434,0.00023364426,0.00017852375,0.00023718351,0.00020268661,0.00014263003,0.000010598573,0.00017534918,0.0000028673076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012661357,0.00008893243,0.00036352203,0.00019790325,0.00031884652,0.0000042416773,0.00026821365,0.000008258077,0.9856529,0.00049441116,0.0020070248,0.009329561],"study_design_scores_gemma":[0.0025517147,0.00090827746,0.008842403,0.0005947018,0.00019349545,0.000021672204,0.00029696155,0.005109693,0.9548739,0.0019432199,0.023801036,0.0008628769],"about_ca_topic_score_codex":0.00013273563,"about_ca_topic_score_gemma":0.000034065033,"teacher_disagreement_score":0.1801269,"about_ca_system_score_codex":0.000013153882,"about_ca_system_score_gemma":0.00012916351,"threshold_uncertainty_score":0.95277363},"labels":[],"label_agreement":null},{"id":"W4406043541","doi":"10.1002/ctd2.70028","title":"The FACTs trial for Fabry disease highlights the promise and challenges of gene therapy","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Fabry disease; Genetic enhancement; Disease; Medicine; Clinical trial; Intensive care medicine; Genetics; Gene; Biology; Internal medicine","score_opus":0.11327105626559682,"score_gpt":0.39222756544341353,"score_spread":0.2789565091778167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406043541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8498764,0.057817448,0.00046227017,0.08940873,0.0001699378,0.0017688061,0.00006621623,0.000008244738,0.00042195243],"genre_scores_gemma":[0.9724818,0.026435811,0.00003351926,0.00020942066,0.00015581594,0.00009969312,0.00001723034,0.0000059431704,0.0005607895],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990925,0.000086504726,0.0003100121,0.00020114824,0.00019494476,0.00011486306],"domain_scores_gemma":[0.9976765,0.0019935612,0.000039704395,0.00014790337,0.000066785215,0.00007556661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043091204,0.00008195048,0.00019208959,0.000020599055,0.00017414377,0.000030718722,0.000074726966,0.00005666168,0.000003539527],"category_scores_gemma":[0.00026197874,0.000037644662,0.00014305853,0.000050218216,0.00047684947,0.00007272951,0.000013590137,0.00010463106,3.3545567e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2603504,0.0017956445,0.037996244,0.00063014036,0.0010128615,0.000008489918,0.00044929347,0.0000046611513,0.00014146445,0.26547882,0.00054425537,0.43158773],"study_design_scores_gemma":[0.05633043,0.0006523511,0.86033756,0.000081213126,0.00013141266,9.373519e-7,0.00009296975,0.00030495084,0.00009942734,0.05426819,0.027606923,0.00009364959],"about_ca_topic_score_codex":0.0000037900375,"about_ca_topic_score_gemma":0.000010514671,"teacher_disagreement_score":0.8223413,"about_ca_system_score_codex":0.0000020228272,"about_ca_system_score_gemma":0.00020160196,"threshold_uncertainty_score":0.17569718},"labels":[],"label_agreement":null},{"id":"W4408377438","doi":"10.1002/ctd2.70042","title":"Towards a one‐time cure for Fabry disease: Lentivirus‐mediated haematopoietic stem and progenitor cell gene therapy","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Haematopoiesis; Genetic enhancement; Progenitor cell; Lentivirus; Stem cell; Disease; Biology; Gene; Virology; Medicine; Immunology; Cancer research; Genetics; Internal medicine; Human immunodeficiency virus (HIV); Viral disease","score_opus":0.05765890817216945,"score_gpt":0.35705818515470394,"score_spread":0.2993992769825345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408377438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96830916,0.017323602,0.0042002085,0.0076878434,0.00011208212,0.001496845,0.00040588313,0.0000401943,0.000424185],"genre_scores_gemma":[0.9938784,0.0019553818,0.00038280975,0.000556816,0.00015288612,0.00013814741,0.00026624385,0.000020698917,0.0026486001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854666,0.00007897852,0.00041972878,0.00042461086,0.00030810124,0.0002219158],"domain_scores_gemma":[0.99895334,0.0005335755,0.00004382088,0.0001501613,0.000105479296,0.00021360953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002655631,0.00016199703,0.0003803661,0.00007297988,0.00011493293,0.00006599341,0.000071711926,0.00013659998,0.000043026237],"category_scores_gemma":[0.00007494883,0.00012881073,0.00020822912,0.00015047342,0.00030665667,0.00016839238,0.000028561444,0.00019246631,0.0000101263395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013596501,0.0047231745,0.7919558,0.0025529708,0.0011739216,0.00007473493,0.00026882192,0.0000052125424,0.0040179556,0.003744233,0.0020903233,0.17579633],"study_design_scores_gemma":[0.01426717,0.0005388055,0.9596175,0.00028962316,0.00036669383,0.000005326232,0.000048633818,0.002293875,0.0012366362,0.011260869,0.009722819,0.0003520307],"about_ca_topic_score_codex":0.000004735734,"about_ca_topic_score_gemma":0.0000018018948,"teacher_disagreement_score":0.1754443,"about_ca_system_score_codex":0.000007545277,"about_ca_system_score_gemma":0.00041361942,"threshold_uncertainty_score":0.5252749},"labels":[],"label_agreement":null},{"id":"W4408384398","doi":"10.1002/ctd2.70038","title":"Commentary on ‘Lentivirus‐mediated gene therapy for Fabry disease: 5‐year end‐of‐study results from the Canadian FACTS trial’","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fondazione Telethon; European Commission","keywords":"Genetic enhancement; Lentivirus; Medicine; Fabry disease; Virology; Clinical trial; Disease; Oncology; Gene; Pediatrics; Genetics; Biology; Internal medicine; Human immunodeficiency virus (HIV); Viral disease","score_opus":0.08319845578048332,"score_gpt":0.387003429268415,"score_spread":0.3038049734879317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408384398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9450827,0.0008981126,0.000095735944,0.04705285,0.00024697062,0.00222548,0.0039420575,0.000009736864,0.00044631874],"genre_scores_gemma":[0.9921429,0.00029585292,0.000026826563,0.005283922,0.00022828006,0.00007020764,0.0017318849,0.000010689353,0.00020942459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984187,0.0001874494,0.000526674,0.00034088586,0.000344277,0.00018205005],"domain_scores_gemma":[0.9960746,0.0033585236,0.0000558054,0.00025173172,0.00007048272,0.00018885368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054268504,0.00012569748,0.00029032596,0.00006784444,0.00019071205,0.000039740986,0.00012283797,0.00008458984,0.00004043753],"category_scores_gemma":[0.00052339537,0.00008123731,0.00019659837,0.00014562035,0.0002670254,0.000079038764,0.000014978759,0.00023158483,0.000004445834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21105483,0.0034962601,0.74392617,0.00003107987,0.0010169598,0.000024477367,0.00036735839,0.0000133985395,0.000028889874,0.0008293626,0.013233871,0.025977347],"study_design_scores_gemma":[0.065311305,0.0007388449,0.92125636,0.000058065234,0.000107692395,5.5266163e-8,0.00009264429,0.00011462263,0.000024228573,0.0025083479,0.009703381,0.00008442941],"about_ca_topic_score_codex":0.013567992,"about_ca_topic_score_gemma":0.021816757,"teacher_disagreement_score":0.17733021,"about_ca_system_score_codex":0.00001829694,"about_ca_system_score_gemma":0.0006456818,"threshold_uncertainty_score":0.99603254},"labels":[],"label_agreement":null},{"id":"W4411532226","doi":"10.1002/ctd2.70064","title":"Therapeutic potential of the annexin A family in atherosclerosis","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Heart and Stroke Foundation of Canada","keywords":"Inflammation; Annexin; Cancer research; Apoptosis; Medicine; Endothelial dysfunction; Annexin A5; Annexin A2; Therapeutic approach; Bioinformatics; Immunology; Cell biology; Biology; Disease; Internal medicine; Flow cytometry; Biochemistry","score_opus":0.02105540759027744,"score_gpt":0.3015199610812025,"score_spread":0.28046455349092503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411532226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473125,0.0016962868,0.00208426,0.0006609316,0.00011155267,0.0001054994,0.00002901292,0.0000014567761,0.00057973736],"genre_scores_gemma":[0.99872255,0.00030187145,0.00005036047,0.00054477644,0.000043521977,0.000006177821,0.000009667296,0.000003403024,0.00031768394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994298,0.000057244375,0.00023016284,0.00015553372,0.000058117934,0.000069148955],"domain_scores_gemma":[0.99980843,0.000024846207,0.000029590825,0.000108331704,0.000016064098,0.0000127661715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013502552,0.000058329308,0.000094708936,0.000015289404,0.000031045853,0.000010544401,0.00008431534,0.000083295665,0.0000030935803],"category_scores_gemma":[0.000016337675,0.0000391729,0.00012069837,0.0000725354,0.00017949709,0.0000049066434,0.000028962315,0.000067175875,2.983883e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033976417,0.00038688406,0.7780955,0.000034381752,0.00010200506,3.4950855e-7,0.000021413365,0.00020107097,0.1906639,0.01352082,0.0001432245,0.016490689],"study_design_scores_gemma":[0.000690412,0.000048598966,0.9898561,0.000033099594,0.000012689802,2.3211925e-7,0.000016911039,0.000094834686,0.0027998611,0.0049251453,0.0014739308,0.000048139555],"about_ca_topic_score_codex":0.00001482707,"about_ca_topic_score_gemma":0.000029946923,"teacher_disagreement_score":0.21176066,"about_ca_system_score_codex":6.2837773e-7,"about_ca_system_score_gemma":0.000063008614,"threshold_uncertainty_score":0.15974244},"labels":[],"label_agreement":null}]}